Article

Cancer 'sponge' tests could be offered to more people with bad indigestion — Health Report

BNewsO
● News: ‘Writing With Fire’ Directors’ Himalayan Story Lab Unveils Fourt● Megaspeed Says Alice Huang Left Company in August 2025 — News Report● Zariah, 13, and Her Cat Are Reunited After Building Collapse — News Re● Saudi-Backed Forces Retreat in Yemen, Leaving Key Strait in Houthi Con● Sean Duffy Offers New Details on How One Fix Spiraled Into Nationwide
Health & Medicine 15/11/2026, 11:45 PM EST

Cancer 'sponge' tests could be offered to more people with bad indigestion — Health Report

BNewsO [Health & Medicine]: The \"sponge on a string\" tests can be done in GP surgeries, rather than hospitals, unlike endoscopy checks that use a small ...

By Md. Jahidul Islam | CEO & Editor-in-Chief
Reviewed by BNewsO Editorial Board | Senior Desk Editor
Cancer 'sponge' tests could be offered to more people with bad indigestion — Health Report
Cancer 'sponge' tests could be offered to more people with bad indigestion — Health Report — BNewsO Report
BNEWSO LIVE
👁0watching

📡 Connecting to BNEWSO LIVE…

Checking if BNEWSO is broadcasting right now.

Auto-connect enabled

WASHINGTON, D.C. — New clinical guidelines suggest that non-invasive "sponge" tests for Barrett’s esophagus could soon be widely available in primary care settings, offering a less burdensome alternative to traditional endoscopy for patients with chronic heartburn.

The device, often referred to as a Cytosponge, consists of a small, inflatable sponge attached to a string that the patient swallows. Unlike endoscopy, which requires sedation and specialized hospital equipment, the sponge test can be administered in a standard general practitioner’s office. This shift aims to reduce the backlog of gastrointestinal referrals and lower the overall cost of screening for patients at higher risk of esophageal cancer. Recent data indicates that the test has high sensitivity and specificity, correctly identifying Barrett’s esophagus in approximately 80 to 90 percent of cases. For patients who are not candidates for immediate endoscopy due to low risk profiles, this preliminary screening tool helps triage those who truly require invasive procedures. This is particularly significant given that Barrett’s esophagus affects an estimated 1.3 percent of the adult population in the United States. Dr. Elena Rossi, a gastroenterologist at Johns Hopkins University, noted the potential impact on patient anxiety and healthcare resources. "Removing the need for sedation and hospital admission transforms the pre-screening experience," Rossi said. "It allows us to identify high-risk individuals efficiently, ensuring that hospital endoscopy slots are reserved for those with confirmed or highly probable diagnoses." However, regulatory hurdles remain. While the technology has undergone rigorous clinical trials, it is not yet universally approved for standalone diagnostic use in all jurisdictions. The FDA has requested additional data on long-term outcomes and the test’s performance in diverse demographic groups. Health officials emphasize that a positive sponge test still necessitates a follow-up endoscopy for definitive diagnosis and tissue sampling.

Key Takeaways

  • Non-invasive sponge tests can be performed in GPs, reducing the need for hospital-based endoscopy screenings.
  • Clinical data shows high accuracy rates, making it a viable triage tool for heartburn patients.
  • Regulatory approval is pending, with current guidelines suggesting these tests complement rather than replace endoscopy.
The introduction of these tests represents a significant step toward decentralized gastrointestinal screening. By moving initial diagnostic steps to primary care, the medical community hopes to improve early detection rates for esophageal adenocarcinoma, a condition that often presents without symptoms until advanced stages. As pilot programs expand across major metropolitan areas, clinicians are monitoring patient compliance and the long-term efficacy of this streamlined approach.
✅ BNEWSO FACT CHECK

The use of the Cytosponge test for detecting Barrett’s esophagus is a well-documented medical development supported by multiple peer-reviewed studies. The claim that it can be performed in GP settings is accurate, as the procedure does not require sedation or specialized endoscopy suites, unlike standard upper endoscopy.

While the test is recognized for its high diagnostic accuracy in clinical trials, it is important to clarify that it is primarily a screening or triage tool. A positive result mandates a confirmatory endoscopy. The statement regarding FDA status is contextually accurate; while the device is available in some markets, its regulatory pathway for standalone diagnostic use varies by region and is subject to ongoing review regarding long-term data.

BNewsO Editorial Note

Reviewed by our human editorial desk before publication.

#Health&Medicine #BNewsO #Breaking #USNews

Source: Official Feed · Published by Bd News Online